Who owns Artios Pharma?

Artios Pharma is currently owned by Sofinnova Partners, through Sofinnova Crossover Fund I, since 2020.

When did Sofinnova Partners acquire Artios Pharma?

Sofinnova Partners acquired Artios Pharma in 2020 (active for 6 years).

Home/Companies/Biotech/Artios Pharma

Artios Pharma

Biotech·

UK·Active·6yr hold

Artios Pharma is a healthcare company, headquartered in United Kingdom.

Entry

2020

Hold

6yr

Status

Active

Est. EV

–

Most recent investor

Sofinnova Partners

2 ownership periods

Key facts

HQUnited Kingdom

SectorHealthcare

UK company developing a pipeline of DNA Damage Response inhibitors for cancer treatment, backed by Cancer Research UK collaboration.

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Start free

Already a member? Sign in

More from Sofinnova Crossover Fund I

Other portfolio companies in the same fund.

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Last updated April 2026 · Sourced from public filings